- Raised $1.2M Series C led by ExitValley, Dec 2025
- Raised $1.2M Series B led by PipelBiz, Aug 2020
- Raised $2M Series A, Apr 2016
About
Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., focused on developing therapies targeting inflammatory processes involved in the pathogenesis of obesity and insulin resistance, with a focus on treating and preventing Type 2 Diabetes. The company has developed a protected platform of drugs based on extensive investigation of animal models of human diseases, aiming to offer proven treatments for multiple indications. Their platform drugs act as potent anti-inflammatory, strong iron-chelating, and antibiotic agents. The company is advancing a pipeline of products that demonstrate vast potential for treating Type 2 Diabetes, and has received approval from the Israeli Ministry of Health for conducting clinical trials using its newly developed oral dose drug on Type 2 Diabetes patients.
Funding history · 3 rounds · $4.4M total
Headcount over time
Q&A
- What is Concenter BioPharma's primary focus?
- Concenter BioPharma develops drugs for the treatment and prevention of Type 2 Diabetes.
- How many employees does Concenter BioPharma have?
- Concenter BioPharma has 1-10 employees.
- When was Concenter BioPharma founded?
- Concenter BioPharma was founded in January 2014.
- What is the total amount of funding Concenter BioPharma has raised to date?
- Concenter BioPharma has raised a total of $4,373,000 USD.
- When was Concenter BioPharma's most recent funding round and who were the lead investors?
- Concenter BioPharma's most recent funding round was a crowdfunding round in January 2026, with ExitValley as a lead investor.
- Who are the co-founders of Concenter BioPharma?
- The co-founders of Concenter BioPharma are Dror Chevion (Co-founder & CEO) and Prof. Mordechai (Mottie) Chevion (Co-founder & CSO).
- What is Concenter BioPharma's current product stage?
- Concenter BioPharma's product is currently in the clinical trial stage.
- What is the primary sector of Concenter BioPharma?
- Concenter BioPharma's primary sector is Health Tech & Life Sciences.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | concenterbiopharma.com |
|---|---|
| linkedin.com/company/9496898 | |
| facebook.com/concenterbiopharma |
Identifiers & details
| Legal name | Concenter BioPharma Ltd. |
|---|---|
| Founded | 2019 |
| Employees (exact) | 2 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | concenterbiopharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516018678 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-05-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — annual_report (3), shares_capital (1), violation (1) |
| Registered address | היהלום 18 תל מונד |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-26 | דו~ח שנתי-הקצאת מניות |
| 2026-01-12 | העברת מניות |
| 2026-01-12 | דו~ח שנתי-הסרת דירקטור |
| 2026-01-12 | עדכון הפרה |
| 2026-01-12 | דו~ח שנתי-עדכון מען דיגיטלי |